Navigation Links
Disease and Therapy Review: Bladder Cancer Now Available at ReportsandReports
Date:6/29/2010

m/market-reports/disease-and-therapy-review-c">http://www.reportsandreports.com/market-reports/disease-and-therapy-review-c hronic-obstructive-pulmonary-disease/)

Disease and Therapy Review: Gastroesophageal Reflux Disease (GERD) (http://www.reportsandreports.com/market-reports/disease-and-therapy-review-g astroesophageal-reflux-disease-ger/)

Disease and Therapy Review: Asthma( http://www.reportsandreports.com/market-reports/disease-and-therapy-review-as thma/)

Disease and Therapy Review: Impetigo( http://www.reportsandreports.com/market-reports/disease-and-therapy-review-im petigo/)

Disease and Therapy Review: Onychomycosis ( http://www.reportsandreports.com/market-reports/disease-and-therapy-review-on ychomycosis/)

Disease and T
'/>"/>

SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
2. Gladstone scientists uncover potential mechanism of memory loss in Alzheimers disease
3. Cleveland Clinic-Led Research Uncovers New Mechanism That Heightens Risk of Heart Disease
4. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
5. Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases
6. Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States
7. TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimers Disease
8. Juvaris BioTherapeutics Announces Six Scientific Presentations at Infectious Diseases Society of America (IDSA) Meeting October 6, 2007
9. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
10. K-State Research Leading to Software to Help Nations Cattle Producers Identify Biosecurity Risks, Evaluate Impact of Cow-Calf Diseases Online
11. AAAAI: Call for Entries: Have You Written a Story on Allergic Disease? Win $1000
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 2015 Glenn Keet, CEO of ... of EMR/EHR Clinical Data Integration with EDC Systems ” ... Washington, DC on June 14th-18th. , During the presentation, ... systems with EDC, and will examine the value of ... and electronic health records/electronic medical records integration. , ...
(Date:5/28/2015)... Dr. Carl Peck, MD, Chairman of ... Williams, MD, has joined the firm as a ... top tier consultants whose expertise and professional stature ... company’s clients. Premier Experts collaborate to design and ... their medical products, pursue optimal regulatory pathways, build ...
(Date:5/27/2015)... 27, 2015 RXi Pharmaceuticals Corporation (NASDAQ: ... discovering and developing innovative therapies primarily in the ... has commenced a public offering of shares of ... its common stock and overallotment purchase rights to ... of common stock, warrants and overallotment purchase rights ...
(Date:5/27/2015)... Expanding in a big way into the Japanese ... recently inked a deal with Arthur Mokuda, president ... the largest endodontic distributor in Japan. The move represents ... Biomed, which manufactures Grey MTA Plus® and the newly ... have won renown from dentists around the world. , ...
Breaking Biology Technology:Clinovo Presents at the DIA 2015 51st Annual Meeting in Washington, DC on June 14th-18th 2Former CEO and Chair of the Council of Experts at the USP, Roger L. Williams, MD, Joins NDA Partners as a Premier Expert Consultant 2RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 2RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 3Dental Manufacturer Avalon Biomed Inks Major Deal with Japanese Distributor 2Dental Manufacturer Avalon Biomed Inks Major Deal with Japanese Distributor 3
... Reportlinker.com announces that a new market research report ... Global Marine Biotechnology Industry ... analyzes the Global markets for Marine Biotechnology in ... Biomaterials, Marine Bioactive Substances, and Others. The Major ...
... MYL ) today announced its financial results for the three and ... for 2011.   Financial Results ... 2010 compared to $0.33 for the same prior year quarter, an ... the year ended December 31, 2010 compared to $1.30 for the ...
... Feb. 24, 2011 Quest Diagnostics Incorporated (NYSE: ... testing, information and services, announced today that it has ... esoteric laboratory specializing in genetic testing for neurological disorders, ... for $740 million in cash.   Athena ...
Cached Biology Technology:Reportlinker Adds Global Marine Biotechnology Industry 2Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 2Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 3Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 4Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 5Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 6Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 7Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 8Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 9Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 10Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 11Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 12Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 13Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 14Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 15Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 16Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 17Mylan Reports Adjusted Diluted EPS of $0.45 for the Quarter, a 36% Increase over Prior Year Quarter; and $1.61 for the Year, a 24% Increase over Prior Year 18Quest Diagnostics to Acquire Athena Diagnostics, Establishing Leading Position in Rapidly Growing Neurology Testing Market 2Quest Diagnostics to Acquire Athena Diagnostics, Establishing Leading Position in Rapidly Growing Neurology Testing Market 3Quest Diagnostics to Acquire Athena Diagnostics, Establishing Leading Position in Rapidly Growing Neurology Testing Market 4
(Date:4/14/2015)... 14, 2015  HYPR Corp. today announced it ... ) Alliance tm , an industry consortium transforming ... to share technology and collaborate to deliver open ... more secure and private, and easier to use. ... that protects sensitive user information and eliminates the ...
(Date:4/13/2015)... 2015 According to a ... Market Forecast & Opportunities, 2020", the global biometrics market ... 14% till 2020. The biometrics market is garnering ... and review of biometric management systems. The constant ... with greater efficiency, are resulting in increasing installation ...
(Date:4/10/2015)... DUBLIN , April 10, 2015 ... the addition of the "Security Competitive Profiles - ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , NEC will continue to ... solutions to the market, with a company focus on ... solution anticipated. Winning opportunities in the ...
Breaking Biology News(10 mins):HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2NEC Security Competitive Profile 2015 2
... Hopkins University researchers have created biodegradable nanosized particles ... and viscous mucus secretions to deliver a sustained-release ... nanoparticles, which degrade over time into harmless components, ... suffering from dozens of health conditions, including diseases ...
... the likely origin of the Devil Facial Tumour Disease (DFTD) ... team of scientists has discovered. Devil Facial Tumour ... devils and was first reported in 1996. It is spread ... characterised by large tumours, mostly on the face and mouth, ...
... chemical modification on an important muscle protein, a University of ... potentially lead to new treatments for the conditions. ... of the journal Science , may also have implications ... initially made, most proteins are modified through the addition of ...
Cached Biology News:Biodegradable particles can bypass mucus, release drugs over time 2Biodegradable particles can bypass mucus, release drugs over time 3Nervous culprit found for Tassie devil facial tumor disease 2Unusual protein modification involved in muscular dystrophy, cancer 2
...
Human LAIR2 Biotinylated Affinity Purified PAb...
The ELISA Kit for Hepatitis B Surface Antigen (HBsAg) is an in vitro enzyme immunoassay for the detection of HBsAg in human serum or plasma....
PGF1α-d4 contains 4 deuterium atoms at the 3, 3', 4, and 4' positions. It is intended for use as an internal standard for the quantification of PGF1α by GC- or LC-mass spectrometry....
Biology Products: